Aetiological factors of Budd-Chiari syndrome in Algeria

Table 2 Clinical and laboratory characteristics at diagnosis

Demographic parameters
Age (yr)	34 (16-72)
M/F (n)	45/70
Distribution by age, n (%)
< 20 yr	8 (9)
20-40 yr	63 (72)
> 40 yr	29 (34)
Clinical parameters n (%)
Disease onset
Acute	8.7 (10)
Chronic	63.5 (73)
Subacute	27.8 (32)
Ascites	62.6 (72)
Hepatomegaly	62.6 (72)
Splenomegaly	42.6 (49)
Thoraco-abdominal venous collaterals	43.5 (50)
Lumber venous collaterals	11.3 (13)
Hepatic encephalopathy	3.5 (4)
Jaundice	40 (46)
Lower limb oedema	24.3 (28)
Biological parameters
ALT (ULN)	2.5 (1-60)
Bilirubin (mg/dL)	20.58 (3-265)
Prothrombin time (%)	57 (14-98)
Haemoglobin (g/dL)	11.7 (3-17)
RBC (106/mm3)	4.5 (1.7-7.9)
WBC (103/mm3)	7.7 (1.3-21.5)
Platelet count (/mm3)	263212 (29000-695000)
Albumin (g/L)	29.4 (16.7-45)
Thrombocytosis n (%)	20 (23)
Erythrocytosis n (%)	11.3 (13)
Hyperleucocytosis n (%)	25.2 (29)
Cholestasis n (%)	73.9 (85)
Hyperbilirubinaemia n (%)	41.7 (48)
Elevated liver enzymes n (%)	49.6 (57)
Liver failure n (%)	61.7 (71)
Renal failure n (%)	9.5 (11)

ALT: Alanine aminotransferase; ULN: Upper limit of normal; M/F: Male/female; RBC: Red blood cells; WBC: White blood cells.